Warby Parker Inc.
NYSE:WRBYMedical - Instruments & Supplies
+$0.92 today
- Market cap
- $3.07B
- Beta
- 1.97
- P/E (TTM)
- 2305.1
- EPS (TTM)
- $0.01
Volume 5.90M
Average 2.81M
WRBY Common Stock Issued
Cash raised by issuing new shares.
Warby Parker Inc.NYSE: WRBY
Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026
Common stock issued growth accelerates
Q2 FY2026 common stock issued of $2.14M rose 71.9% year over year, ahead of the +45.9% change in trailing-twelve-month common stock issued. Over 3 fiscal years it compounded at -9.6% a year.
Context
- Common stock issued amounted to 0.3% of revenue in FY2025, down 0.3 pp from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +71.9% holds above the trailing-twelve-month pace of +45.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 2.36M USD
- Year-over-year change
- -48.9%
- 4-year CAGR
- -41.4%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.36M | -48.9% |
| FY2024 | 2024-12-31 | 4.63M | +61.2% |
| FY2023 | 2023-12-31 | 2.87M | -10.3% |
| FY2022 | 2022-12-31 | 3.2M | -84.0% |
| FY2021 | 2021-12-31 | 20.04M | — |
Common Stock Issued vs competitors
How WRBY compares with its peers on the latest reported figures
- WRBY's LTM Jun 2026 common stock issued of $3.22M is the 6th largest of the 10 companies compared; the peer median is $624K.
- Its year-over-year change of +45.9% is the 2nd highest of 6, against a peer median of -95.5%.
- Common stock issued amounts to 0.4% of revenue for WRBY, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $14.62M | -96.9% | +64.1% | 9.4% | |
| LTM Mar 2026 | $8M | +272.9% | +25.3% | 3.1% | |
| LTM Jun 2026 | $7.49M | -98.9% | — | 0.6% | |
| LTM Mar 2026 | $4.9M | -34.7% | -38.6% | 0.2% | |
| LTM Jul 2026 | $3.64M | — | — | 0.2% | |
| LTM Jun 2026 | $3.22M | +45.9% | -9.6% | 0.4% | |
| LTM Jun 2026 | $624K | -95.5% | -11.4% | 0.0% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding WRBY) | $624K | -95.5% | +7.0% | 0.2% | |
Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (144.27M) | (110.39M) | (63.2M) | (20.39M) | 1.64M |
| Depreciation & Amortization | 21.87M | 31.86M | 38.55M | 45.87M | 50.28M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 107.15M | 98.03M | 70.51M | 47.29M | 34.54M |
| Change in Working Capital | (24.5M) | (14.55M) | 5.81M | 19.26M | 17.55M |
| Accounts Receivables | (392K) | (451K) | (345K) | (169K) | (1.34M) |
| Inventory | (18.62M) | (11.79M) | 6.61M | 9.89M | 7.83M |
| Accounts Payables | (11.11M) | (7.94M) | 1.63M | 689K | 8.5M |
| Other Working Capital | 5.63M | 5.64M | (2.09M) | 8.85M | 2.55M |
| Other Non-Cash Items | 7.76M | 5.42M | 9.32M | 6.72M | 6.78M |
| Operating Cash Flow | (31.99M) | 10.37M | 60.99M | 98.74M | 110.79M |
| Capital Expenditures | (48.51M) | (60.18M) | (53.67M) | (64.03M) | (67.05M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (1M) | (2M) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (48.51M) | (60.18M) | (54.67M) | (66.03M) | (67.05M) |
| Debt Repayment | 31.61M | 91K | 0 | 0 | 0 |
| Common Stock Issued | 20.04M | 3.2M | 2.87M | 4.63M | 2.36M |
| Common Stock Repurchased | (8.09M) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (20.56M) | 0 | 0 | 333K | (14.36M) |
| Financing Cash Flow | 23M | 3.29M | 2.87M | 4.96M | (12M) |
| Effect of Forex Changes | (161K) | (1.31M) | (882K) | (406K) | 457K |
| Net Change in Cash | (57.67M) | (47.83M) | 8.31M | 37.27M | 32.2M |
| Free Cash Flow | (80.51M) | (49.81M) | 7.32M | 34.71M | 43.74M |
Warby Parker Inc.
NYSE:WRBY
Intrinsic Alpha fair value
Locked
Current Price
$28.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.